Linda Burkly serves as Executive at Editas Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Linda Burkly has executed 7 insider transactions totaling $80.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 3, 2025 involved selling 713 shares valued at $1.5K.
Linda Burkly currently holds 68,777 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Linda Burkly has been a net seller of EDIT stock. They have purchased $0 and sold $80.6K worth of shares.
Linda Burkly's most recent insider trade was on Dec 3, 2025, when they sold 713 shares at $2.15 per share.
Get notified when new Form 4 filings are submitted
| $2.60 |
| Discretionary |
| Jul 31, 2025 | EDIT | $12.8K | Sale | 5,121 | $2.49 | Discretionary |
| Jul 25, 2024 | EDIT | $64.4K | Sale | 11,886 | $5.42 | Planned |
| Mar 2, 2024 | EDIT | $0 | Award | 15,055 | $N/A | Discretionary |
| Mar 2, 2024 | EDIT | $0 | Award | 24,800 | $N/A | Discretionary |
| Jul 24, 2023 | EDIT | $0 | Award | 45,167 | $N/A | Discretionary |